« Return to News | Awards & Advancement

StudyManager awarded Army contract for mild TBI study

Tuesday, September 20, 2011 02:46 PM

StudyManager, a leading provider of clinical trial management software (CTMS) and electronic data capture (EDC) solutions, has reported that BalanceSense awarded StudyManager an eight-site, phase II Army contract to implement Evolve CTMS and EDC.

BalanceSense sought a flexible, easy to use solution for the management of clinical data captured by physical therapists treating returning troops with mild-trauma brain injuries, and to centralize, track and manage study progress.

“I investigated StudyManager on the recommendation of a colleague. StudyManager Evolve provides us with CTMS and EDC integrated into one easy-to-use system, which will allow us to manage both the study and the study data in one central location. We have a small team responsible for managing all aspects of the study, and Evolve will enhance the overall quality of the input and output of data in treating troops with mild-trauma brain injuries,” said Dr. Karen Atkins, PhD, PT, BalanceSense.

“It’s a privilege for StudyManager and Evolve to have been selected as one of BalanceSense’s civilian partners to support much needed treatment for our returning troops. We look forward to their clinical and operational success with this study,” said Sue Blecman, vice president of sales, StudyManager.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs

More Jobs

 

Copyright © 1995-2013 CenterWatch.